{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:32:48Z","timestamp":1773671568737,"version":"3.50.1"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/gme.0b013e31805170eb","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T08:02:57Z","timestamp":1177574577000},"page":"357-369","source":"Crossref","is-referenced-by-count":96,"title":["The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women"],"prefix":"10.1097","volume":"14","member":"276","reference":[{"key":"R1-8-20210227","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jama.1995.03530220066035","article-title":"Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group.","volume":"274","author":"Guyatt","year":"1995","journal-title":"JAMA"},{"key":"R2-8-20210227","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/bmj.317.7156.427","article-title":"Guidelines for clinical guidelines editorial.","volume":"317","author":"Jackson","year":"1998","journal-title":"BMJ"},{"key":"R4-8-20210227","first-page":"67","article-title":"The North American Menopause Society develops consensus opinions editorial.","volume":"5","author":"Boggs","year":"1998","journal-title":"Menopause"},{"key":"R5-8-20210227","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0015-0282(99)00113-2","article-title":"Estrogen receptor and expression in the vaginal walls and uterosacral ligaments of premenopausal and postmenopausal women.","volume":"71","author":"Chen","year":"1999","journal-title":"Fertil Steril"},{"key":"R6-8-20210227","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1067\/mob.2001.119627","article-title":"Expression of estrogen receptor isoforms and messenger RNA in vaginal tissue of premenopausal and postmenopausal women.","volume":"185","author":"Gebhart","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R8-8-20210227","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0015-0282(01)02377-9","article-title":"Vaginal-cervical epithelial permeability decreases after menopause.","volume":"76","author":"Gorodeski","year":"2001","journal-title":"Fertil Steril"},{"key":"R9-8-20210227","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3109\/00016349309068039","article-title":"Factors influencing vaginal cytology, pH and bacterial flora in elderly women.","volume":"72","author":"Milsom","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R10-8-20210227","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.ajog.2003.12.015","article-title":"Vaginal pH is similar to follicle-stimulating hormone for menopause diagnosis.","volume":"190","author":"Roy","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R11-8-20210227","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0378-5122(94)00863-3","article-title":"The vaginal epithelium in the postmenopause-cytology, histology and pH as methods of assessment.","volume":"21","author":"Nilsson","year":"1995","journal-title":"Maturitas"},{"key":"R12-8-20210227","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0360-3016(93)90455-5","article-title":"Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma.","volume":"27","author":"Bruner","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-8-20210227","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/01.GME.0000151655.10243.48","article-title":"Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer.","volume":"12","author":"Conde","year":"2005","journal-title":"Menopause"},{"key":"R14-8-20210227","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00042192-200103000-00006","article-title":"Factors related to sexual function in postmenopausal women with a history of breast cancer.","volume":"8","author":"Greendale","year":"2001","journal-title":"Menopause"},{"key":"R15-8-20210227","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1200\/JCO.1999.17.8.2371","article-title":"Predictors of sexual health in women after a breast cancer diagnosis.","volume":"17","author":"Ganz","year":"1999","journal-title":"J Clin Oncol"},{"key":"R16-8-20210227","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/1097-0142(20010901)92:5<1288::AID-CNCR1450>3.0.CO;2-E","article-title":"Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: a prospective study.","volume":"92","author":"Arora","year":"2001","journal-title":"Cancer"},{"key":"R17-8-20210227","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.2005.04.2499","article-title":"Sexual problems in younger women after breast cancer surgery.","volume":"24","author":"Burwell","year":"2006","journal-title":"J Clin Oncol"},{"key":"R18-8-20210227","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF01806673","article-title":"Breast cancer survivors: psychosocial concerns and quality of life.","volume":"38","author":"Ganz","year":"1996","journal-title":"Breast Cancer Res Treat"},{"key":"R19-8-20210227","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2003.04.196","article-title":"Breast cancer in younger women: reproductive and late health effects of treatment.","volume":"21","author":"Ganz","year":"2003","journal-title":"J Clin Oncol"},{"key":"R20-8-20210227","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1634\/theoncologist.11-2-96","article-title":"The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors.","volume":"11","author":"Knobf","year":"2006","journal-title":"Oncologist"},{"key":"R21-8-20210227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-006-9260-6","article-title":"Quality of life of postmenopausal women in the ATAC (\"Arimidex,\" Tamoxifen Alone or in Combination) trial after completion of 5 years' adjuvant treatment for early stage breast cancer.","volume":"100","author":"Cella","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"R22-8-20210227","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1200\/JCO.1999.17.9.2659","article-title":"Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 study.","volume":"17","author":"Day","year":"1999","journal-title":"J Clin Oncol"},{"key":"R23-8-20210227","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S1470-2045(06)70767-7","article-title":"Arimidex, Tamoxifen, Alone or in Combination Trialists' Group. Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long term safety analysis of the ATAC trial.","volume":"7","year":"2006","journal-title":"Lancet Oncol"},{"key":"R24-8-20210227","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"R25-8-20210227","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1001\/jama.295.23.joc60075","article-title":"Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.","volume":"295","author":"Land","year":"2006","journal-title":"JAMA"},{"key":"R26-8-20210227","first-page":"558","article-title":"Adverse events reported by postmenopausal women in controlled trials with raloxifene.","volume":"93","author":"Davies","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R27-8-20210227","first-page":"346","article-title":"Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy.","volume":"101","author":"Parsons","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R28-8-20210227","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1200\/JCO.2004.08.029","article-title":"Quality of life of postmenopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant breast cancer trial.","volume":"22","author":"Fallowfield","year":"2004","journal-title":"J Clin Oncol"},{"key":"R29-8-20210227","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1200\/JCO.2005.11.181","article-title":"Assessment of quality of life in MA 17: a randomized placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women.","volume":"23","author":"Whelan","year":"2005","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"R30-8-20210227","doi-asserted-by":"crossref","first-page":"S1056","DOI":"10.1158\/1078-0432.CCR-05-2185","article-title":"Managing patients on endocrine therapy: focus on quality-of-life issues.","volume":"12","author":"Whelan","year":"2006","journal-title":"Clin Canc Res"},{"key":"R31-8-20210227","first-page":"228","article-title":"Postmenopausal vaginal atrophy and atrophic vaginitis.","volume":"314","author":"Pandit","year":"1997","journal-title":"Am J Med Sci"},{"key":"R32-8-20210227","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1440-0960.2001.00524.x","article-title":"Menopause and the skin.","volume":"42","author":"Wines","year":"2001","journal-title":"Australas J Dermatol"},{"key":"R35-8-20210227","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0015-0282(16)56474-7","article-title":"Comparative study: Replens versus local estrogen in menopausal women.","volume":"61","author":"Nachtigall","year":"1994","journal-title":"Fertil Steril"},{"key":"R36-8-20210227","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1471-0528.1996.tb09741.x","article-title":"A comparative study of safety and efficacy of continuous low dose oestradiol released from a vaginal ring compared with conjugated equine oestrogen vaginal cream in the treatment of postmenopausal urogenital atrophy.","volume":"103","author":"Ayton","year":"1996","journal-title":"BJOG"},{"issue":"Suppl","key":"R37-8-20210227","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/0378-5122(95)00963-9","article-title":"Clinical trial of the estradiol vaginal ring in the U.S.","volume":"22","author":"Nachtigall","year":"1995","journal-title":"Maturitas"},{"key":"R38-8-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1447-0756.2001.tb01266.x","article-title":"The effect of estradiol vaginal tablet and conjugated estrogen cream on urogenital symptoms in postmenopausal women: a comparative study.","volume":"27","author":"Manonai","year":"2001","journal-title":"J Obstet Gynaecol Res"},{"key":"R39-8-20210227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00042192-200007030-00005","article-title":"17-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.","volume":"7","author":"Rioux","year":"2000","journal-title":"Menopause"},{"key":"R40-8-20210227","first-page":"215","article-title":"Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.","volume":"84","author":"Handa","year":"1994","journal-title":"Obstet Gynecol"},{"key":"R41-8-20210227","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(96)02612-7","article-title":"Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.","volume":"71","author":"Barentsen","year":"1997","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R42-8-20210227","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s001920050040","article-title":"Local treatment of urogenital atrophy with an estradiol-releasing vaginal ring: a comparative and a placebo-controlled multicenter study. Vaginal Ring Study Group.","volume":"10","author":"Casper","year":"1999","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R43-8-20210227","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0002-9378(94)90074-4","article-title":"A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.","volume":"171","author":"Henriksson","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"R44-8-20210227","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1471-0528.2000.tb10408.x","article-title":"Oestradiol-releasing vaginal ring versus oestriol vaginal pessaries in the treatment of bothersome lower urinary tract symptoms.","volume":"107","author":"Lose","year":"2000","journal-title":"BJOG"},{"key":"R45-8-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/13697130500087016","article-title":"Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.","volume":"8","author":"Weisberg","year":"2005","journal-title":"Climacteric"},{"key":"R46-8-20210227","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0028-2243(92)90059-8","article-title":"Low-dose 17-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.","volume":"44","author":"Eriksen","year":"1992","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R47-8-20210227","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1034\/j.1600-0412.2000.079004293.x","article-title":"Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.","volume":"79","author":"Dugal","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R48-8-20210227","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0020-7292(03)00200-5","article-title":"Local estrogen treatment in patients with urogenital symptoms.","volume":"82","author":"Simunic","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"R49-8-20210227","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0378-5122(91)90092-5","article-title":"Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints.","volume":"13","author":"Foidart","year":"1991","journal-title":"Maturitas"},{"key":"R50-8-20210227","first-page":"159","article-title":"Efficiency of vaginal ovules of estriol for treatment of symptoms of menopause.","volume":"19","author":"Garcia","year":"1993","journal-title":"Investigacion Medica Internacional"},{"key":"R51-8-20210227","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1089\/154099902762203704","article-title":"Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.","volume":"11","author":"Crandall","year":"2002","journal-title":"J Women's Health"},{"issue":"Suppl","key":"R52-8-20210227","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/0378-5122(95)00956-6","article-title":"Urogenital ageing: an old problem newly recognized.","volume":"22","author":"Bachmann","year":"1995","journal-title":"Maturitas"},{"key":"R53-8-20210227","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/13697139909038062","article-title":"Development and validation of a physical examination scale to assess vaginal atrophy and inflammation.","volume":"2","author":"Greendale","year":"1999","journal-title":"Climacteric"},{"key":"R54-8-20210227","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0378-5122(95)00955-8","article-title":"Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women.","volume":"23","author":"Bygdeman","year":"1996","journal-title":"Maturitas"},{"key":"R55-8-20210227","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199309093291102","article-title":"A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections.","volume":"329","author":"Raz","year":"1993","journal-title":"N Engl J Med"},{"key":"R57-8-20210227","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0378-5122(93)90059-Q","article-title":"Oestradiol-releasing vaginal ring for the treatment of postmenopausal urogenital atrophy.","volume":"16","author":"Smith","year":"1993","journal-title":"Maturitas"},{"key":"R58-8-20210227","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00042192-200205000-00006","article-title":"Treatment of urogenital atrophy with low-dose estradiol: preliminary results.","volume":"9","author":"Santen","year":"2002","journal-title":"Menopause"},{"key":"R59-8-20210227","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/jama.293.8.935","article-title":"Effects of estrogen with and without progestin on urinary incontinence.","volume":"293","author":"Hendrix","year":"2005","journal-title":"JAMA"},{"key":"R60-8-20210227","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/01.AOG.0000180394.08406.15","article-title":"Postmenopausal hormone therapy: does it cause incontinence?","volume":"106","author":"Steinauer","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R61-8-20210227","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0002-9378(99)70597-1","article-title":"A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infection in postmenopausal women.","volume":"180","author":"Eriksen","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R62-8-20210227","first-page":"222","article-title":"SOCG clinical practice guidelines. The detection and management of vaginal atrophy. Number 145, May 2004.","volume":"88","year":"2005","journal-title":"Int J Gynaecol Obstet"},{"key":"R63-8-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00024677-200403020-00003","article-title":"Optimizing gonadotropin-releasing hormone agonist therapy in women with endometriosis.","volume":"3","author":"Olive","year":"2004","journal-title":"Treat Endocrinol"},{"key":"R64-8-20210227","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1056\/NEJM197801262980406","article-title":"Absorption of estrogens from vaginal creams.","volume":"298","author":"Rigg","year":"1978","journal-title":"N Engl J Med"},{"key":"R65-8-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/annonc\/mdj127","article-title":"Caution: vaginal estradiol appears to be contraindicated in postmenopausal women on adjuvant aromatase inhibitors.","volume":"17","author":"Kendall","year":"2006","journal-title":"Ann Oncol"},{"key":"R66-8-20210227","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/cmt.6.3.248.256","article-title":"Effect of raloxifene on sexual function in postmenopausal women.","volume":"6","author":"Kessel","year":"2003","journal-title":"Climacteric"},{"key":"R67-8-20210227","first-page":"45","article-title":"Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.","volume":"10","author":"Pinkerton","year":"2003","journal-title":"Menopause"},{"key":"R68-8-20210227","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.breast.2004.02.009","article-title":"Breast cancer patients' experiences on endocrine therapy: monitoring with a checklist for patients on endocrine therapy (C-PET).","volume":"13","author":"Malinovszky","year":"2004","journal-title":"Breast"},{"key":"R69-8-20210227","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1054\/bjoc.2001.1703","article-title":"Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.","volume":"84","author":"Marttunen","year":"2001","journal-title":"Br J Cancer"},{"key":"R70-8-20210227","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9378(98)80001-X","article-title":"Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations.","volume":"178","author":"Sobel","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R71-8-20210227","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0002-9378(99)70042-6","article-title":"Serum and tissue hormone levels of vaginally and orally administered estradiol.","volume":"180","author":"Tourgeman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R72-8-20210227","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0015-0282(00)01640-X","article-title":"Endocrine and clinical effects of micronized estradiol administered vaginally or orally.","volume":"75","author":"Tourgeman","year":"2001","journal-title":"Fertil Steril"},{"key":"R73-8-20210227","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/S0015-0282(01)01786-1","article-title":"Is there evidence for preferential delivery of ovarian estradiol to the endometrium?","volume":"75","author":"Tourgeman","year":"2001","journal-title":"Fertil Steril"},{"key":"R74-8-20210227","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/jnci\/92.13.1054","article-title":"Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial.","volume":"92","author":"Ganz","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R75-8-20210227","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00520-005-0847-y","article-title":"A practical guide to the management of menopausal symptoms in breast cancer patients.","volume":"13","author":"Gainford","year":"2005","journal-title":"Support Care Cancer"},{"key":"R76-8-20210227","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1188\/03.ONF.393-407","article-title":"Comprehensive menopausal assessment: an approach to managing vasomotor and urogenital symptoms in breast cancer survivors.","volume":"30","author":"Zibecchi","year":"2003","journal-title":"Oncol Nurs Forum"},{"key":"R77-8-20210227","doi-asserted-by":"crossref","first-page":"R535","DOI":"10.1186\/bcr1035","article-title":"Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence.","volume":"7","author":"Col","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"R78-8-20210227","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/jnci\/dji198","article-title":"Hormone replacement therapy for breast cancer survivors: an unanswered question?","volume":"97","author":"Zielinski","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"R79-8-20210227","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1300\/J077v20n03_03","article-title":"Women like me: reflections on health and hormones from women treated for breast cancer.","volume":"20","author":"Bond","year":"2002","journal-title":"J Psychosocial Oncol"},{"key":"R80-8-20210227","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00006199-200201000-00003","article-title":"Carrying on: the experience of premature menopause in women with early stage breast cancer.","volume":"51","author":"Knobf","year":"2002","journal-title":"Nurs Res"},{"key":"R81-8-20210227","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/gme.0b013e31803167ab","article-title":"Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.","volume":"14","year":"2007","journal-title":"Menopause"},{"key":"R82-8-20210227","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1592\/phco.21.5.464.34486","article-title":"Urogenital atrophy: prevention and treatment.","volume":"21","author":"Willhite","year":"2001","journal-title":"Pharmacotherapy"},{"key":"R83-8-20210227","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1701-2163(16)30662-4","article-title":"The detection and management of vaginal atrophy.","volume":"26","author":"Johnston","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"issue":"Suppl 4","key":"R84-8-20210227","first-page":"56S","article-title":"Genitourinary tract changes.","volume":"104","year":"2004","journal-title":"Obstet Gynecol"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-200714030-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T16:46:12Z","timestamp":1707842772000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-200714030-00008"}},"subtitle":["2007 position statement of The North American Menopause Society"],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":79,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e31805170eb","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}